DCI Seminar Series (1.25.17)

December 19, 2016
By: Karen E. Butler, Director of Communications, Duke Cancer Institute

William Kim, MDOn Wednesday, Jan. 25, William Kim, MD, Associate Professor of Medicine and Genetics, UNC Chapel Hill, will present “Molecular Subtypes of Bladder Cancer.”

The Kim Lab is focused on understanding the genetic and epigenetic events involved in the initiation and progression of renal cell carcinoma (RCC) and bladder cancer. Through NextGeneration sequencing of primary human tumors and the use of genetically engineered mouse models (GEMMs), as well as in vitro systems, our goal is to identify the critical genomic and epigenetic changes that are drivers of RCC and bladder cancer. Our ultimate goal is to elucidate the functional consequences of these genomic events in order to pinpoint novel, high impact therapeutic targets for therapy.

The DCI Seminar Series lecture will be held on Wednesday, Jan. 25, in the Trent Semans Center, Great Hall. The lecture begins at 8:10 a.m. and ends at 9 a.m. Larson’s address will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. All are invited to attend. For more information, contact Erin Carr.